SANDOSTATIN

Solution for injection/infusion, 0.1mg/ml
RxActive license

Active substance (INN)

octreotide

Pharmaceutical form

Pharmaceutical formSolution for injection/infusion
Strength0.1mg/ml
PackagingUkupno 5 ampula sa po 1ml rastvora za injekciju/infuziju u kartonskoj kutiji
ManufacturerNovartis Pharma Stein AG, Switzerland
Therapeutic groupSystemic hormonal preparations (H01CB02)
Marketing authorization holder"NOVARTIS PHARMA SERVICES AG" DIO STRANOG DRUŠTVA PODGORICA
Authorization dateNovember 5, 2024

Analogs in Montenegro

6

Other medicines with the same active substance

OKTREOTID TEVARx
Powder and solvent for prolonged-release suspension for injection, 30mgMerckle GmbH
OKTREOTID TEVARx
Powder and solvent for prolonged-release suspension for injection, 10mgMerckle GmbH
OKTREOTID TEVARx
Powder and solvent for prolonged-release suspension for injection, 20mgMerckle GmbH
SANDOSTATIN LARRx
Powder and solvent for suspension for injection, 10mgNovartis Farmaceutica S.A.
SANDOSTATIN LARRx
Powder and solvent for suspension for injection, 20 mgNovartis Farmaceutica S.A.
SANDOSTATIN LARRx
Powder and solvent for suspension for injection, 30mgNovartis Farmaceutica S.A.
Source: CInMED register